Feb 03, 2022 / 01:00PM GMT
Presentation
Feb 03, 2022 / 01:00PM GMT
=====================
Corporate Participants
=====================
* Alan Hippe
Roche Holding AG - Chief Financial & Information Officer
* Bruno Eschli
* Severin Schwan
Roche Holding AG - CEO & Executive Director
* Thomas Schinecker
Roche Holding AG - CEO of Roche Diagnostics
* William N. Anderson
Roche Holding AG - CEO of Roche Pharmaceuticals
=====================
Conference Call Participants
=====================
* Emmanuel Douglas Papadakis
Deutsche Bank AG, Research Division - Research Analyst
* Eric Le Berrigaud
* Keyur Parekh
Goldman Sachs Group, Inc., Research Division - Equity Analyst
* Luisa Caroline Hector
Joh. Berenberg, Gossler & Co. KG, Research Division - Co-Head of Global Pharmaceutical Team
* Matthew Weston
Crédit Suisse AG, Research Division - MD and Co-Head of European Pharmaceutical Equity Research
* Michael Leuchten
UBS Investment Bank, Research Division -
Roche Holding AG
(XSWX:ROP)
CHF
332
+6.8 (+2.09%)
Market Cap: 264.93 Bil
Enterprise Value: 286.73 Bil
PE Ratio: 20.70
PB Ratio: 7.82
GF Score: 79/100 Full Year 2021 Roche Holding AG Earnings Presentation Transcript
Feb 03, 2022 / 01:00PM GMT
Release Date Price:
CHF348.45
(-2.42%)
Already have an account? Log in
Get the full story
| Access to All Earning Calls and Stock Analysis | |
| 30-Year Financial on one screen | |
| All-in-one Stock Screener with unlimited filters | |
| Customizable Stock Dashboard | |
| Real Time Insider Trading Transactions | |
| 8,000+ Institutional investors’ 13F holdings | |
| Powerful Excel Add-in and Google sheets Add-on | |
| All data downloadable | |
| Quick customer support | |
| And much more... |

30-Day 100% money back guarantee
Subscription fee may be tax deductible.
Excellent 

4.6 out of 5
Trustpilot